![Markus Hosang](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Markus Hosang
Direttore/Membro del Consiglio presso
Aleva Neurotherapeutics SA
Profilo
Markus Hosang is currently Vice Chairman at Cardior Pharmaceuticals GmbH since 2022, Director at Anergis SA, Aleva Neurotherapeutics SA, and ImmunOs Therapeutics AG, Managing Partner at BioMedPartners AG since 2005, and Member of the Supervisory Board at AYOXXA Biosystems GmbH.
Former roles include Vice Chairman of the Supervisory Board at Vaximm AG, Vice Chairman at Unitectra Ltd., Director of the Supervisory Board at Avontec GmbH and SCT-Spinal Cord Therapeutics GmbH, Director at Okairos AG, Chief Scientific Officer-Integrated Medicine and Vice President at Roche Holding AG, Venture Partner at MPM BioImpact LLC, and Member of the Supervisory Board at Hookipa Biotech AG.
Education includes a doctorate from ETH Zürich Human Resources conferred in 1981.
Posizioni attive di Markus Hosang
| Società | Posizione | Inizio |
|---|---|---|
BioMedPartners AG
 BioMedPartners AG Investment ManagersFinance BioMedPartners invests in companies located in Switzerland, Germany and neighboring Western Europe. The firm focuses on biotechnology, emerging pharmaceutical, medical technology and other healthcare-related industries such as diagnostics or platform technologies. It participates in seed and early stage capital transactions. It also makes follow-on investments and acts a lead or co-lead investor. | Investitore di Private Equity | 01/01/2005 |
Aleva Neurotherapeutics SA
 Aleva Neurotherapeutics SA Electronic Equipment/InstrumentsElectronic Technology Develops next-generation implants for deep brain stimulation therapy | Direttore/Membro del Consiglio | 29/08/2011 |
Anergis SA
 Anergis SA Pharmaceuticals: GenericHealth Technology Provides allergy vaccines | Direttore/Membro del Consiglio | - |
Cardior Pharmaceuticals GmbH
 Cardior Pharmaceuticals GmbH Pharmaceuticals: MajorHealth Technology Engages in discovery and development of therapies that target RNA as a means to prevent, repair & reverse diseases of the hearts | Direttore/Membro del Consiglio | 06/04/2022 |
AYOXXA Biosystems GmbH
 AYOXXA Biosystems GmbH BiotechnologyHealth Technology Provides biotechnology research and development services | Direttore/Membro del Consiglio | - |
ImmunOs Therapeutics AG
 ImmunOs Therapeutics AG BiotechnologyHealth Technology Engages in discovering and developing novel human immunomodulatory proteins | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Markus Hosang
| Società | Posizione | Fine |
|---|---|---|
Hookipa Biotech AG
 Hookipa Biotech AG Medical SpecialtiesHealth Technology Develops new generation prophylactic and therapeutic vaccines | Direttore/Membro del Consiglio | 18/11/2024 |
Unitectra Ltd.
 Unitectra Ltd. Miscellaneous Commercial ServicesCommercial Services Provides licensing, research contracts and IP management services | Presidente | 14/10/2015 |
Avontec GmbH
 Avontec GmbH Pharmaceuticals: MajorHealth Technology Discovers and develops novel therapeutic treatments for inflammatory disease | Direttore/Membro del Consiglio | 16/06/2010 |
| ░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | - |
| ░░░░░ ░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Formazione di Markus Hosang
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
65
Relazioni di 1° grado
15
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 15 |
|---|---|
Roche Holding AG
 Roche Holding AG Pharmaceuticals: MajorHealth Technology Operates as a research-focused healthcare company with combined focus in pharmaceuticals and diagnostics | Health Technology |
MPM BioImpact LLC
 MPM BioImpact LLC Investment ManagersFinance MPM Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of biotechnology, healthcare and life science sectors. It participates in early stage capital transactions. | Finance |
Avontec GmbH
Avontec GmbH Pharmaceuticals: MajorHealth Technology Discovers and develops novel therapeutic treatments for inflammatory disease | Health Technology |
SCT-Spinal Cord Therapeutics GmbH
 SCT-Spinal Cord Therapeutics GmbH Miscellaneous Commercial ServicesCommercial Services Specializes in pre-clinical research | Commercial Services |
Okairos AG
 Okairos AG Pharmaceuticals: MajorHealth Technology Discovers and develops preventive and therapeutic vaccines against human chronic infectious diseases | Health Technology |
BioMedPartners AG
BioMedPartners AG Investment ManagersFinance BioMedPartners invests in companies located in Switzerland, Germany and neighboring Western Europe. The firm focuses on biotechnology, emerging pharmaceutical, medical technology and other healthcare-related industries such as diagnostics or platform technologies. It participates in seed and early stage capital transactions. It also makes follow-on investments and acts a lead or co-lead investor. | Finance |
Vaximm AG
 Vaximm AG Miscellaneous Commercial ServicesCommercial Services Develops immunotherapies for cancer treatment | Commercial Services |
Unitectra Ltd.
Unitectra Ltd. Miscellaneous Commercial ServicesCommercial Services Provides licensing, research contracts and IP management services | Commercial Services |
Anergis SA
Anergis SA Pharmaceuticals: GenericHealth Technology Provides allergy vaccines | Health Technology |
Aleva Neurotherapeutics SA
Aleva Neurotherapeutics SA Electronic Equipment/InstrumentsElectronic Technology Develops next-generation implants for deep brain stimulation therapy | Electronic Technology |
Hookipa Biotech AG
Hookipa Biotech AG Medical SpecialtiesHealth Technology Develops new generation prophylactic and therapeutic vaccines | Health Technology |
AYOXXA Biosystems GmbH
AYOXXA Biosystems GmbH BiotechnologyHealth Technology Provides biotechnology research and development services | Health Technology |
ETH Zürich Human Resources
 ETH Zürich Human Resources Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cardior Pharmaceuticals GmbH
Cardior Pharmaceuticals GmbH Pharmaceuticals: MajorHealth Technology Engages in discovery and development of therapies that target RNA as a means to prevent, repair & reverse diseases of the hearts | Health Technology |
ImmunOs Therapeutics AG
ImmunOs Therapeutics AG BiotechnologyHealth Technology Engages in discovering and developing novel human immunomodulatory proteins | Health Technology |
